December 04, 2025

AI-generated social media content as an opportunity for cancer prevention

AI-generated social media content as an opportunity for cancer prevention

Health communication content created using artificial intelligence (AI) can reach people on social media more effectively and encourage more interaction than conventional posts. This opens up new opportunities for effective and cost-efficient information campaigns—especially in the field of cancer prevention and early detection. The prerequisite is that AI-generated content must be used transparently, validated by experts, and integrated into quality-assured institutional communication.

AI-generated social media content promotes a healthy lifestyle

For people under the age of 30, social media platforms are the primary source of information. This applies to entertainment and lifestyle as well as politics, society, and health. Information on healthy lifestyles, early detection examinations, and education about medical misinformation – “If you want to reach people in this age group, there’s no way around social media,” says Nicolas Merl, psychologist at the German Cancer Research Center. However, public health institutions often lack the necessary resources to create high-quality social media posts on a consistent basis. AI-generated content could be a solution to this dilemma.

AI content attracts more attention and interaction

Yet how is AI-generated content accepted and perceived by users? A team led by first author Nicolas Merl conducted a systematic review and meta-analysis to find out. The researchers evaluated 33 international studies published between 2020 and 2025 that compare AI-generated content with content created by humans.

The result: AI-generated posts led to an average of 12 percent more interactions—such as likes, shares, comments, or clicks—than comparable content created by humans. The quality of the posts was also frequently rated positively. Although this trend was not statistically significant in all studies, there was a clear tendency in favor of AI-based content. “Posts that are both perceived as credible and emotionally engaging are particularly effective,” explains lead author Merl.

Opportunities and responsibilities for cancer prevention

AI-generated social media content enables wide reach at low cost, personalized prevention messages, multilingual and accessible information, and rapid response to new information needs. At the same time, however, the researchers emphasize the need for clear guidelines. AI must not lead to uncertainty or the spread of unwanted misinformation. “Generative AI offers enormous opportunities for public health, but only if transparency, expert review, and ethical rules are adhered to,” says study leader Titus Brinker from the DKFZ. He and his team therefore call for the following requirements for the use of AI-generated content in health communication:

  • Transparency about the use of AI (“created with AI”),
  • Professional review of content by experts,
  • Avoidance of manipulative emotional representations,
  • Quality assurance through institutional standards

Publication: Nicolas B. Merl, Franziska Schramm, Christoph Wies, Jana T. Winterstein, Titus J. Brinker: Generative AI in social media health communication: systematic review and meta-analysis of user engagement with implications for cancer prevention.
European Journal of Cancer, 2025, https://doi.org/10.1016/j.ejca.2025.116114

Our latest News

discover more
Tailor-Made Fertilization

Tailor-Made Fertilization

Excessive fertilization in agriculture weakens crops, threatens drinking water quality, and harms the soil. Researchers at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB are now developing an alternative fertilizer that is fully biodegradable, supplies plants exclusively with the nutrients they need, and prevents over-fertilization. More information in German below: Jahr für Jahr werden […]

Two German Cancer Awards for Researchers at Heidelberg University’s Faculty of Medicine

Two German Cancer Awards for Researchers at Heidelberg University’s Faculty of Medicine

Professor Dr. Jessica Hassel, Faculty of Medicine Heidelberg at Heidelberg University and Head of the Skin Cancer Center at Heidelberg University Hospital and the National Center for Tumor Diseases (NCT) Heidelberg, has been awarded in the category “Clinical Research.” Professor Dr. Dr. Felix Sahm, also from the Faculty of Medicine Heidelberg, Department of Neuropathology at […]

Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease

Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease

Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease Paris, March 31, 2026. The European Commission has granted a conditional marketing authorisation for Rezurock (belumosudil) for the treatment of chronic graft-versus-host disease (GVHD) in adults and in children aged 12 years and older with a body weight of at least 40 kg. The medicine is to […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp